Access the full text.
Sign up today, get DeepDyve free for 14 days.
G. Albers, P. Amarenco, J. Easton, R. Sacco, P. Teal (2004)
Antithrombotic and thrombolytic therapy for ischemic stroke: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.Chest, 126 3 Suppl
J. Staessen, Ji-Guang Wang, L. Thijs (2003)
Cardiovascular prevention and blood pressure reduction: a quantitative overview updated until 1 March 2003Journal of Hypertension, 21
D.L. Bhatt, P.G. Steg, E.M. Ohman (2006)
REACH Registry Investigators. International prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombosisJAMA, 295
M. Flather, S. Yusuf, L. Køber, M. Pfeffer, A. Hall, G. Murray, C. Torp-Pedersen, S. Ball, J. Pogue, L. Moye, E. Braunwald (2000)
Long-term ACE-inhibitor therapy in patients with heart failure or left-ventricular dysfunction: a systematic overview of data from individual patientsThe Lancet, 355
(2004)
El tratamiento hipolipemiante intensivo frente al moderado con estatinas tras síndromes coronarios agudos
A. Tonkin, P. Alyward, D. Colquhoun, P. Glasziou, P. Harris, D. Hunt, A. Keech, S. MacMahon, P. Magnus, D. Newel, P. Nestel, N. Sharpe, J. Shaw, R. Simes, P. Thompson, A. Thompson, M. West, H. White, S. Simes, W. Hague, S. Caleo, Jane Hall, Andrew Martin, S. Mulray, P. Barter, L. Beilin, R. Collins, J. McNeil, P. Meier, H. Willimott, D. Smithers, P. Wallace, J. Baker, M. Hobbs, D. Sullivan, N. Anderson, G. Hankey, J. Watson, M. Arulchelvam, S. Chup, J. Daly, J. Hanna, A. Leach, M. Lee, J. Loughhead, H. Lundie-Jenkin, J. Morrison, S. Netting, A. Nguyen, H. Pater, R. Philip, G. Pinna, D. Rattos, S. Ryerson, V. Sazhin, R. Walsh, A. Claque, M. Mackie, J. Yallop, K. Boss, M. Shepard, J. Leach, M. Gandy, J. Joughin, J. Seabrook, R. Abraham, J. Allen, F. Bates, I. Beinart, E. Breed, D. Brown, N. Bunyan, D. Calvert, T. Campbell, D. Condon‐Paoloni, B. Conway, L. Coupland, J. Crowe, N. Cunio, B. Cuthbert, N. Cuthbert, S. D'arcy, P. Davidson, B. Dwyer, J. England, C. Friend, G. Fulcher, S. Grant, K. Hellestrand, M. Kava, L. Kritharides, D. McGill, H. McKee, A. Mclean, M. Neaverson, G. Nelson, M. O'Neill, C. Onuma, F. O'Reilly (1998)
Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels.The New England journal of medicine, 339 19
K. Hardie, G. Hankey, K. Jamrozik, R. Broadhurst, C. Anderson (2003)
Ten-Year Survival After First-Ever Stroke in the Perth Community Stroke StudyStroke: Journal of the American Heart Association, 34
A. Olsson, J. Mcmurray, G. Thorgeirsson, C. Spaulding, J. Slattery, K. Pyörälä, O. Faergeman, R. Wright, Kåre Berg, L. Wilhelmsen, T. Pedersen, T. Miettinen, H. White, J. Kjekshus, M. Gnant (1994)
Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). 1994.Atherosclerosis. Supplements, 5 3
J. Shepherd, S.M. Cobbe, I. Ford (1995)
Prevention of coronary heart disease with pravastatin in men with hypercholesterolemiaWest of Scotland Coronary Prevention Study Group. N Engl J Med, 20
S.R. Mehta, S. Yusuf, R.J. Peters (2001)
Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE studyLancet, 9281
J. Downs, M. Clearfield, S. Weis, E. Whitney, D. Shapiro, P. Beere, A. Langendorfer, E. Stein, W. Kruyer, A. Gotto (1998)
Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study.JAMA, 279 20
Huyen Tran, Sonia Anand (2004)
Oral antiplatelet therapy in cerebrovascular disease, coronary artery disease, and peripheral arterial disease.JAMA, 292 15
M.P. McGowan (2004)
For the Treating to New Target (TNT) Study Group. There is no evidence for an increase in acute coronary syndromes after short-term abrupt discontinuation of statins in stable cardiac patientsCirculation, 16
R. Gibbons, K. Chatterjee, J. Daley, J. Douglas, S. Fihn, J. Gardin, Mark Grunwald, D. Levy, B. Lytle, R. O'rourke, William Schafer, Sankey Williams, J. Ritchie, M. Cheitlin, K. Eagle, T. Gardner, A. Garson, R. Russell, T. Ryan, Sidney Smith (1999)
ACC/AHA/ACP-ASIM guidelines for the management of patients with chronic stable angina: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Patients With Chronic Stable Angina).Journal of the American College of Cardiology, 33 7
S. Yusuf, P. Sleight, J. Pogue (2000)
Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patientsThe Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med, 3
H. Diener, J. Bogousslavsky, L. Brass, C. Cimminiello, L. Csiba, M. Kaste, D. Leys, J. Matías-Guiu, H. Rupprecht (2004)
Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trialThe Lancet, 364
T. Quill, D. Meier (2006)
The big chill--inserting the DEA into end-of-life care.The New England journal of medicine, 354 1
(1994)
Randomised trial of cholesterol lowering in 4444 patients with coronary heart diseaseLancet, 8934
K. Fox (2003)
Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study)The Lancet, 362
M.B. Bottorff (2003)
Update in cardiovascular drug therapy: antiplatelet therapy for atherosclerotic diseaseConsult Pharm, 18
L.A. Harker, J.P. Boissel, A.J. Pilgrim (1999)
Comparative safety and tolerability of clopidogrel and aspirin: results from CAPRIE: CAPRIE Steering Committee and Investigators: clopidogrel versus aspirin in patients at risk of ischaemic eventsDrug Saf, 4
J. Ness, W. Aronow (1999)
Prevalence of Coexistence of Coronary Artery Disease, Ischemic Stroke, and Peripheral Arterial Disease in Older Persons, Mean Age 80 Years, in an Academic Hospital‐Based Geriatrics PracticeJournal of the American Geriatrics Society, 47
D. Clement (1996)
A randomised, blinded, trial of Clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE)The Lancet, 348
E. Selvin, T. Erlinger (2004)
Prevalence of and Risk Factors for Peripheral Arterial Disease in the United States: Results From the National Health and Nutrition Examination Survey, 1999–2000Circulation, 110
Jane Thomas, S. Paranjothy, D. James (2004)
National cross sectional survey to determine whether the decision to delivery interval is critical in emergency caesarean sectionBMJ : British Medical Journal, 328
J. Kondo, T. Sone, Hideyuki Tsuboi, H. Mukawa, I. Morishima, M. Uesugi, T. Kono, Takashi Kosaka, T. Yoshida, Y. Numaguchi, H. Matsui, T. Murohara, K. Okumura (2003)
Effects of low-dose angiotensin II receptor blocker candesartan on cardiovascular events in patients with coronary artery disease.American heart journal, 146 6
J.W. Eikelboom, G.J. Hankey (2004)
Failure of aspirin to prevent atherothrombosis: potential mechanisms and implications for clinical practiceAm J Cardiovasc Drugs, 1
Deepak Bhatt, K. Fox, W. Hacke, P. Berger, H. Black, W. Boden, P. Cacoub, E. Cohen, M. Creager, J. Easton, M. Flather, S. Haffner, C. Hamm, G. Hankey, S. Johnston, K. Mak, J. Mas, G. Montalescot, T. Pearson, P. Steg, S. Steinhubl, M. Weber, D. Brennan, Liz Fabry-Ribaudo, J. Booth, E. Topol (2006)
Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events.The New England journal of medicine, 354 16
S. Yusuf, P. Sleight, J. Pogue, J. Bosch, R. Davies, G. Dagenais (2000)
Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients.The New England journal of medicine, 342 3
Gregory Albers, P. Amarenco, J. Easton, Ralph Sacco, P. Teal (1998)
Antithrombotic and thrombolytic therapy for ischemic stroke.Chest, 114 5 Suppl
E. Grech, D. Ramsdale (2003)
ABC of interventional cardiology: Acute coronary syndrome: unstable angina and non-ST segment elevation myocardial infarctionBMJ, 326
M. Sabatine, C. Cannon, C. Gibson, J. López-Sendón, G. Montalescot, P. Théroux, M. Claeys, F. Cools, K. Hill, A. Skene, C. Mccabe, E. Braunwald (2005)
Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation.The New England journal of medicine, 352 12
E. Grech, D. Ramsdale (2003)
Acute coronary syndrome: unstable angina and non-ST segment elevation myocardial infarction.BMJ, 326
C.P. Cannon, E. Braunwald, C.H. McCabe (2004)
Intensive versus moderate lipid lowering with statins after acute coronary syndromes. Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis in Myocardial Infarction 22 InvestigatorsN Engl J Med, 15
J. Bradberry (2004)
Peripheral arterial disease: pathophysiology, risk factors, and role of antithrombotic therapy.Journal of the American Pharmacists Association : JAPhA, 44 2 Suppl 1
K. Dickstein, J. Kjekshus (2002)
Effects of losartan and captopril on mortality and morbidity in high-risk patients after acute myocardial infarction: the OPTIMAAL randomised trial. Optimal Trial in Myocardial Infarction with Angiotensin II Antagonist LosartanLancet, 9335
M. McGowan (2004)
There Is No Evidence for an Increase in Acute Coronary Syndromes After Short-Term Abrupt Discontinuation of Statins in Stable Cardiac PatientsCirculation, 110
J. Eikelboom, G. Hankey (2004)
Failure of Aspirin to Prevent AtherothrombosisAmerican Journal of Cardiovascular Drugs, 4
E. Antman, D. Anbe, P. Armstrong, Eric Bates, L. Green, M. Hand, J. Hochman, H. Krumholz, F. Kushner, G. Lamas, C. Mullany, J. Ornato, D. Pearle, M. Sloan, Sidney Smith (2004)
ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction--executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1999 Guidelines for the Management of Patients WiThe Canadian journal of cardiology, 20 10
R.L. Sacco, T. Shi, M.C. Zamanillo (1994)
Predictors of mortality and recurrence after hospitalized cerebral infarction in an urban community: the Northern Manhattan Stroke StudyNeurology, 4
H. Diener, L. Cunha, C. Forbes, J. Sivenius, P. Smets, A. Lowenthal (1996)
European Stroke Prevention Study 2. Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke 1 1 ESPS-2 Writing CommitteeJournal of the Neurological Sciences, 143
Rn Sacco, Tianying Shi, M. Zamanillo, De Kargman (1994)
Predictors of mortality and recurrence after hospitalized cerebral infarction in an urban communityNeurology, 44
S. Yusuf (2002)
From the HOPE to the ONTARGET and the TRANSCEND studies: challenges in improving prognosis.The American journal of cardiology, 89 2A
S. MacMahon, A. Rodgers (1994)
Blood pressure, antihypertensive treatment and stroke risk.Journal of hypertension. Supplement : official journal of the International Society of Hypertension, 12 10
S. Yusuf, F. Zhao, S. Mehta, S. Chrolavicius, G. Tognoni, K. Fox, Clopidogrel Investigators (2001)
Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation.The New England journal of medicine, 345 7
G. Petty, Robert Brown, J. Whisnant, J. Sicks, W. O'fallon, D. Wiebers (1998)
Survival and recurrence after first cerebral infarctionNeurology, 50
W. Duvall, D. Vorchheimer (2004)
Multi-Bed Vascular Disease and Atherothrombosis: Scope of the ProblemJournal of Thrombosis and Thrombolysis, 17
P. Rashid, J. Leonardi-Bee, P. Bath (2003)
Blood Pressure Reduction and Secondary Prevention of Stroke and Other Vascular Events: A Systematic ReviewStroke: Journal of the American Heart Association, 34
C. Baigent, C. Sudlow, R. Collins, R. Peto, Antithromboci Collaborat (2002)
Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patientsBMJ : British Medical Journal, 324
AndrewJ. Coats (2002)
MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebocontrolled trialThe Lancet, 360
M. Criqui, R. Langer, A. Fronek, H. Feigelson, M. Klauber, T. McCann, D. Browner (1992)
Mortality over a period of 10 years in patients with peripheral arterial disease.The New England journal of medicine, 326 6
E. Braunwald, E. Antman, John Beasley, R. Califf, M. Cheitlin, J. Hochman, Robert Jones, D. Kereiakes, Joel Kupersmith, T. Levin, C. Pepine, J. Schaeffer, E. Smith, David Steward, P. Théroux, R. Gibbons, Joseph Alpert, D. Faxon, V. Fuster, G. Gregoratos, L. Hiratzka, A. Jacobs, Sidney Smith (2002)
ACC/AHA 2002 guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction--summary article: a report of the American College of Cardiology/American Heart Association task force on practice guidelines (Committee on the Management of PatientsJournal of the American College of Cardiology, 40 7
M.D. Flather, S. Yusuf, L. Kober (2000)
Long-term ACE-inhibitor therapy in patients with heart failure or left-ventricular dysfunction: a systematic overview of data from individual patients. ACE-inhibitor Myocardial Infarction Collaborative GroupLancet, 9215
J. Shepherd, S. Cobbe, A. Lorimer, J. Mckillop, J. Ford, C. Packard, P. Macfarlane, C. Isles, M. Oliver, A. Lever, B. Brown, J. Ledingham, S. Pocock, B. Rifkind, B. Vallance, D. Ballantyne, L. Anderson, D. Duncan, S. Kean, A. Lawrence, J. McGrath, K. Montgomery, J. Norrie, M. Percy, E. Pomphrey, A. Whitehouse, P. Cameron, P. Parker, F. Porteous, L. Fletcher, C. Kilday, D. Shoat, S. Latif, J. Kennedy, M. Bell, R. Birrell, M. Mellies, J. Meyer, W. Campbell (1996)
West of Scotland Coronary Prevention Study: Identification of high-risk groups and comparison with other cardiovascular intervention trialsThe Lancet, 348
B. Pitt, P. Poole-Wilson, R. Segal, Felipe Martinez, K. Dickstein, John Camm, Marvin Konstam, G. Riegger, George Klinger, J. Neaton, Divakar Sharma, B. Thiyagarajan (2000)
Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: randomised trial—the Losartan Heart Failure Survival Study ELITE IIThe Lancet, 355
P. Armstrong, Yuling Fu, Wei-Ching Chang, E. Topol, C. Granger, A. Betriu, F. Werf, Kerry Lee, R. Califf (1998)
Acute Coronary Syndromes in the GUSTO-IIb Trial Prognostic Insights and Impact of Recurrent IschemiaCirculation, 98
K. Dickstein, J. Kjekshus (2002)
Effects of losartan and captopril on mortality and morbidity in high-risk patients after acute myocardial infarction: the OPTIMAAL randomised trialThe Lancet, 360
S. Johnston, P. Fayad, P. Gorelick, D. Hanley, P. Shwayder, D. Husen, T. Weiskopf (2003)
Prevalence and knowledge of transient ischemic attack among US adultsNeurology, 60
C. Hennekens, C. Hennekens, F. Sacks, F. Sacks, A. Tonkin, A. Tonkin, J. Jukema, R. Byington, R. Byington, B. Pitt, B. Pitt, D. Berry, S. Berry, N. Ford, Andrew Walker, Kannan Natarajan, Sheng-Lin Chen, F. Fiedorek, René Belder (2003)
Additive benefits of pravastatin and aspirin to decrease risks of cardiovascular disease: randomized and observational comparisons of secondary prevention trials and their meta-analyses.Archives of internal medicine, 164 1
F. Sacks, M. Pfeffer, L. Moye, J. Rouleau, J. Rutherford, T. Cole, L. Brown, J. Warnica, J. Arnold, C. Wun, B. Davis, E. Braunwald (1996)
The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators.The New England journal of medicine, 335 14
G.W. Petty, R.D. Brown, J.P. Whisnant (1998)
Survival and recurrence after first cerebral infarction: a population-based study in Rochester, Minnesota, 1975 through 1989Neurology, 1
E. Braunwald, E. Antman, J. Beasley, R. Califf, M. Cheitlin, J. Hochman, Robert Jones, D. Kereiakes, J. Kupersmith, T. Levin, C. Pepine, J. Schaeffer, E. Smith, D. Steward, P. Théroux, R. Gibbons, J. Alpert, K. Eagle, D. Faxon, V. Fuster, T. Gardner, G. Gregoratos, R. Russell, Sidney Smith (2000)
ACC/AHA guidelines for the management of patients with unstable angina and non‐ST segment elevation myocardial infarction: Executive summary and recommendationsCatheterization and Cardiovascular Interventions, 51
F.M. Sacks, M.A. Pfeffer, L.A. Moye (1996)
The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levelsCholesterol and Recurrent Events Trial Investigators. N Engl J Med, 14
Caroline Milton, Prashanthan Sanders, P. Steele (2001)
For personal use. Only reproduce with permission from The Lancet Publishing Group. Late cardiopulmonary complication of ventriculo-atrial shunt
Deepak Bhatt, P. Steg, E. Ohman, A. Hirsch, Y. Ikeda, J. Mas, S. Goto, C. Liau, A. Richard, J. Röther, P. Wilson (2006)
International prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombosis.JAMA, 295 2
J. Shepherd, S. Cobbe, I. Ford, C. Isles, A. Lorimer, P. Macfarlane, J. Mckillop, C. Packard (1995)
Prevention of coronary heart disease with pravastatin in men with hypercholesterolemiaThe New England Journal of Medicine, 333
D. Johnston (2001)
Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6105 individuals with previous stroke or transient ischaemic attackThe Lancet, 358
R. Collins, S. MacMahon (1994)
Blood pressure, antihypertensive drug treatment and the risks of stroke and of coronary heart disease.British medical bulletin, 50 2
S. Steinhubl, Peter Berger, J. III, Edward Fry, A. Delago, C. Wilmer, E. Topol (2002)
Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial.JAMA, 288 19
N. Freemantle, J. Cleland, P. Young, J. Mason, J. Harrison (1999)
β Blockade after myocardial infarction: systematic review and meta regression analysisBMJ, 318
S. Yusuf (2002)
MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20536 high-risk individuals: a randomised placebo-controlled trial. CommentaryThe Lancet, 360
L. Harker, J. Boissel, A. Pilgrim, M. Gent (1999)
Comparative Safety and Tolerability of Clopidogrel and AspirinDrug Safety, 21
M. Dennis (1996)
A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering CommitteeThe Lancet, 348
Atherothrombosis involves the mutually interactive dual mechanistic processes of atherosclerotic plaque progression and thrombus formation. In the setting of acute plaque rupture, resultant thrombus formation precipitates acute ischemic events such as acute coronary syndromes (ACS), stroke, and transient ischemic attack. Peripheral arterial disease is also a manifestation of atherothrombotic disease, and occurs both acutely and as a result of underlying disease progression. Atherothrombotic disease is highly prevalent and imposes a substantial burden on the community. For example, coronary artery disease was the single greatest cause of mortality among men and women in the US and accounted for an estimated $US142.1 billion in health costs in 2005. Activated platelets are the prime mediators of arterial thrombus formation. This review discusses the evidence supporting the use of oral antiplatelet agents with other risk prevention strategies in the long-term secondary prevention of atherothrombotic disease. The most widely used oral antiplatelet agent is aspirin (acetylsalicylic acid), and both aspirin and clopidogrel have proven roles in the management of atherothrombotic disease. Clopidogrel should also be used in combination with aspirin in patients with non-ST-segment elevation ACS and those undergoing percutaneous coronary intervention. Recent data suggest that clopidogrel may have a significant role, with or without fibrinolytic therapy, in the immediate management of ST-segment elevation ACS.
American Journal of Cardiovascular Drugs – Springer Journals
Published: Aug 20, 2012
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.